Copied
 
 
Formål
HistorikStartStop
Selskabets formål er drive forsknings- og udviklingsvirksomhed20.08.201017.06.2022
Virksomheden har ikke ændret Formål i sin levetid.
Ingen nuværende registrering.
Status
HistorikStartStop
OPLØST EFTER FRIVILLIG LIKVIDATION17.06.202217.06.2022
UNDER FRIVILLIG LIKVIDATION21.01.202016.06.2022
NORMAL17.07.200020.01.2020
Ingen nuværende registrering.
Branche
HistorikStartStop
Forskning og eksperimentel udvikling indenfor bioteknologi (721100)01.01.200817.06.2022
Forskning og udvikling inden for naturvidenskab og teknik (731000)17.07.200031.12.2007
Ingen nuværende registrering.
Revision
HistorikStartStop
true15.07.202117.06.2022
false17.07.200014.07.2021
Ingen nuværende registrering.
Revisor
Ingen nuværende registrering.
Form
HistorikStartStop
6017.07.200017.06.2022
Virksomheden har ikke ændret Form i sin levetid.
Ingen nuværende registrering.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
HistorikStartStop
7022236510.12.200417.06.2022
7022236520.10.200326.08.2004
Ingen nuværende registrering.
Navne
Ingen nuværende registrering.
Binavne
HistorikStartStop
ARPIDA A/S17.07.200017.06.2022
COMBIO A/S17.07.200017.06.2022
EVOLVA A/S17.07.200017.06.2022
Ingen nuværende registrering.
Tegningsregel
HistorikStartStop
Virksomheden tegnes af en likvidator21.01.202017.06.2022
Selskabet tegnes af direktøren i forening med bestyrelsesformanden eller af 2 medlemmer af bestyrelsen eller af den samlede bestyrelse20.08.201020.01.2020
Ingen nuværende registrering.
Ansatte
07.05.2024
Kapital
07.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these rules and requirements.
Konklusion (revision):We have audited the financial statements of Evolva Biotech A/S under frivillig likvidation for the financial year 1 January - 31 December 2020, which comprise income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2020 and of the results of the Company's operations for the financial year 1 January - 31 December 2020 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):The liquidator is responsible for the liquidator's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
07.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
07.05.2024
Ingen nuværende registrering.
Ingen historik.